Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 527-531

  Nhu, Nguyen Thi Quynh ^a   Lan, N T N ^b   Phuong, N T N ^a   Van V Chau, N ^c   Farrar, J ^a,d   Caws, M ^a,d  

^a The Hospital for Tropical Diseases   (Viet Nam)

^b Pham Ngoc Thach Hospital   (Viet Nam)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Beijing genotype; Drug resistance; Streptomycin; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GIDB GENE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RPSL GENE; RSS GENE; SPOLIGOTYPING; VIET NAM;

ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RNA, BACTERIAL; SEQUENCE ANALYSIS, RNA; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIETNAM;

EID: 84858676023     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0202     Document Type: Article

References (30)

1. Wright A, Zignol M, Van Deun A, et al. Epidemiology of anti-tuberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 373: 1861-1873.
2. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR TB). Global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.
3. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12: 736-743.
4. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 2010; 10: 103-111.
5. Anh D D, Borgdorff M W, Van L N, et al. Mycobacterium tuberculosis Beijing genotype emerging in Viet Nam. Emerg Infect Dis 2000; 6: 302-305. (Pubitemid 30396388)
6. Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, Niemann S. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 2005; 9: 1161-1167. (Pubitemid 41433807)
7. Hillemann D, Kubica T, Rüsch-Gerdes S, Niemann S. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob Agents Chemother 2005; 49: 1229-1231. (Pubitemid 40327757)
8. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002; 46: 1417-1424. (Pubitemid 34415323)
9. Park Y K, Shin S, Ryu S, et al. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 2005; 63: 165-172.
10. Lipin M Y, Stepanshina V N, Shemyakin I G, Shinnick T M. Association of specifi c mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 2007; 13: 620-626. (Pubitemid 46730669)
11. Huong N T, Lan N T, Cobelens F G, et al. Anti-tuberculosis drug resistance in the south of Viet Nam: prevalence and trends. J Infect Dis 2006; 194: 1226-1232. (Pubitemid 44630967)
12. Sun Y J, Luo J T, Wong S Y, Lee A S. Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore. Clin Microbiol Infect 2010; 16: 287-289.
13. World Health Organization. Global tuberculosis control 2010. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/ publications/2010/9789241564069-eng.pdf Accessed January 2012.
14. Buu T N, Huyen M N, Lan N T N, et al. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis 2009; 13: 900-906.
15. Caws M, Thwaites G, Stepniewska K, et al. Beijing genotype of Mycobacterium tuberculosis is signifi cantly associated with human immunodefi ciency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006; 44: 3934-3939. (Pubitemid 44737232)
16. Caws M, Thwaites G, Dunstan S, et al. The infl uence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008; 4: e1000034.
17. Vree M, Bui D D, Dinh N S, Nguyen V C, Borgdorff M W, Cobelens F G. Tuberculosis trends, Viet Nam. Emerg Infect Dis 2007; 13: 796-797.
18. World Health Organization. Treatment of tuberculosis. Guidelines for national programs. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/publications/tb-treatmentguidelines/en/index.html Accessed January 2012.
19. Quy H T, Buu T N, Cobelens F G J, Lan N T N, Lambregts C S B, Borgdorff M W. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10: 160-166. (Pubitemid 43275539)
20. Streptomycin. Tuberculosis (Edinb) 2008; 88: 162-163.
21. Zhang Y, Yew W W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1320-1330.
22. Bifani P, Mathema B, Campo M, et al. Molecular identifi cation of streptomycin-monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. Emerg Infect Dis 2001; 7: 842-848. (Pubitemid 33121591)
23. Okamoto S, Tamaru A, Nakajima C, et al. Loss of a conserved 7-methylguanosine modifi cation in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol 2007; 63: 1096-1106. (Pubitemid 46188264)
24. Spies F S, da Silva P E, Ribeiro M O, Rossetti M L, Zaha A. Identifi cation of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of effl ux mechanism. Antimicrob Agents Chemother 2008; 52: 2947-2949.
25. Wong S Y, Lee J S, Kwak H K, Via L E, Boshoff H I, Barry C E III. Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011; 55: 2515-2522.
26. Das R, Gupta P, Singh P, Chauhan D S, Katoch K, Katoch V M. Association of mutations in rpsL gene with high degree of streptomycin resistance in clinical isolates of Mycobacterium tuberculosis in India. Indian J Med Res 2009; 129: 108-110.
27. Meier A, Sander P, Schaper K J, Scholz M, Bottger E C. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1996; 40: 2452-2454. (Pubitemid 26367624)
28. Caws M, Duy P M, Tho D Q, Lan N T, Hoa D V, Farrar J. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Viet Nam. J Clin Microbiol 2006; 44: 2333-2337. (Pubitemid 44092394)
29. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914. (Pubitemid 27146535)
30. BACTEC™MGIT™ 960 SIRE kits for the antimycobacterial susceptibility testing of Mycobacterium tuberculosis. Sparks, MD, USA: BD, 2007.